NCT02940925View on ClinicalTrials.gov

TPC vs PF as Induction Chemotherapy Combined With CCRT for Stage IVa-b Nasopharyngeal Carcinoma

PHASE3CompletedINTERVENTIONAL
Enrollment

241

Participants

Timeline

Start Date

October 20, 2016

Primary Completion Date

August 28, 2021

Study Completion Date

August 31, 2021

Conditions
Nasopharyngeal Carcinoma
Interventions
OTHER

Drug: Taxol,cisplatin and capecitabine

Taxol, cisplatin and capecitabine as induction chemotherapy combined with cisplatin concurrent chemoradiotherapy with intensity modulated radiation therapy.

OTHER

Drug: Cisplatin and 5-Fluorouracil

Cisplatin and 5-Fluorouracil as induction chemotherapy combined with cisplatin concurrent chemoradiotherapy with intensity modulated radiation therapy.

Trial Locations (1)

510060

SunYat-senU, Guangzhou

All Listed Sponsors
lead

Sun Yat-sen University

OTHER

NCT02940925 - TPC vs PF as Induction Chemotherapy Combined With CCRT for Stage IVa-b Nasopharyngeal Carcinoma | Biotech Hunter | Biotech Hunter